J. Levy

发表

LIPOSOMAL DELIVERY OF A PHOTOSENSITIZER, BENZOPORPHYRIN DERIVATIVE MONOACID RING A (BPD), TO TUMOR TISSUE IN A MOUSE TUMOR MODEL

A. Jain, A. Richter, E. Waterfield, 1993, Photochemistry and photobiology.

Preferential uptake of benzoporphyrin derivative by leukemic versus normal cells.

J. Levy, C. Jamieson, W. N. McDonald, 1990, Leukemia research.

Tumour scanning with indium-111 dihaematoporphyrin ether.

A. Richter, J. Levy, M. Quastel, 1990, British Journal of Cancer.

The use of the enzyme-linked immunosorbent assay (ELISA) for the detection and quantification of specific antibody from cell cultures.

J. Levy, B. Kelly, L. Sikora, 1979, Immunology.

TARGETING ACTIVATED LYMPHOCYTES WITH PHOTODYNAMIC THERAPY: SUSCEPTIBILITY OF MITOGEN‐STIMULATED SPLENIC LYMPHOCYTES TO BENZOPORPHYRIN DERIVATIVE (BPD) PHOTOSENSITIZATION

A. Jain, M. Obochi, A. Richter, 1995, Photochemistry and photobiology.

Enhanced photodynamic killing of target cells by either monoclonal antibody or low density lipoprotein mediated delivery systems

B. Allison, J. Levy, Dan Liu, 1992 .

The possible role of prostaglandins in mediating immune suppression by nonspecific T suppressor cells.

J. Levy, A. Fulton, 1980, Cellular immunology.

Expression of the mammalian c-fes protein in hematopoietic cells and identification of a distinct fes-related protein

T. Pawson, J. Levy, I. Macdonald, 1985, Molecular and cellular biology.

Photosensitizers in photodynamic therapy.

J. Levy, 1994, Seminars in Oncology.

Photodynamic therapy induces caspase-3 activation in HL-60 cells

J. Levy, D. Granville, D. Hunt, 1997, Cell Death and Differentiation.

Apoptosis associated with esophageal adenocarcinoma: influence of photodynamic therapy.

C. Carthy, J. Levy, D. Granville, 2001, Cancer letters.

Selective depletion of a thymocyte subset in vitro with an immunomodulatory photosensitizer.

B. McManus, J. Levy, D. Granville, 1999, Clinical immunology.

Efficacy of benzoporphyrin derivative, a photosensitizer, in selective destruction of leukemia cells using a murine tumor model.

A. Richter, J. Levy, C. Jamieson, 1993, Experimental hematology.

Dye-mediated photolysis is capable of eliminating drug-resistant (MDR+) tumor cells.

A. Richter, J. Levy, T. Igarashi, 1993, Blood.

Dye-mediated photolysis is capable of eliminating drug-resistant (MDR+) tumor cells

A. Richter, J. Levy, T. Igarashi, 1993 .

Photodynamic killing of human squamous cell carcinoma cells using a monoclonal antibody-photosensitizer conjugate.

J. Levy, M. Chester, S. Jiang, 1991, Journal of the National Cancer Institute.

Suppressor deletion therapy: selective elimination of T suppressor cells in vivo using a hematoporphyrin conjugated monoclonal antibody permits animals to reject syngeneic tumor cells

J. Levy, S. Whitney, Dan Liu, 2004, Cancer Immunology, Immunotherapy.

Development of technology for linking photosensitizers to a model monoclonal antibody.

A. Richter, J. Levy, S. Jiang, 1990, Journal of immunological methods.

Photosensitizing potencies of the structural analogues of benzoporphyrin derivative in different biological test systems.

A. Jain, G. Moreno, C. Salet, 1996, Journal of clinical laser medicine & surgery.

An immunocytochemical investigation with monoclonal antibodies to somatostatin

J. Brown, C. Mcintosh, J. Levy, 2004, Histochemistry.

Evaluation of a model for post-partum arthritis and the role of oestrogen in prevention of MRL-lpr associated rheumatic conditions.

J. Levy, J. Tonzetich, L. Ratkay, 1994, Clinical and experimental immunology.

CAMAL: a new prognostic marker for remission in acute nonlymphoblastic leukemia.

J. Levy, S. Whitney, S. Naiman, 1988, Leukemia research.

The effect of specific cell inactivation on the cellular immune response to ferreodoxin peptides

T. Pearson, D. Kilburn, J. Levy, 1975, European journal of immunology.

Characterization of antigen-binding molecules from T suppressor hybridomas.

J. North, J. Levy, A. T. Stammers, 1988, International reviews of immunology.

Immune Regulation in Neoplasia Dominance of Suppressor Systems

J. Levy, A. T. Stammers, J. Steele, 1987 .

Immune Regulation in Neoplasia

J. Levy, A. T. Stammers, J. Steele, 1987 .

Preliminary characterization of a soluble immunosuppressive molecule from DBA/2 spleen cells using monoclonal antibody immunoadsorbence.

J. Levy, A. T. Stammers, T. Maier, 1985, Cellular immunology.

Abrogation and reconstitution of nonresponsiveness: a correlation with high network connectivity

J. Levy, G. Hoffmann, R. Singhai, 1985, European journal of immunology.

The Lyt phenotype of cells involved in the cytotoxic response to syngeneic tumor and of tumor-specific suppressor cells.

D. Kilburn, J. Levy, T. Maier, 1980, Cellular immunology.

A comparison of the ability of serum and monoclonal antibodies to gastric inhibitory polypeptide to detect immunoreactive cells in the gastroenteropancreatic system of mammals and reptiles

J. Brown, J. Levy, A. Buchan, 2004, Histochemistry.

A monoclonal antibody raised to tumor-specific T cell-derived suppressor factors also recognizes T suppressor inducer factors of the 4-hydroxy-3-nitrophenyl acetyl hapten suppressor network.

V. Kuchroo, M. Dorf, J. Levy, 1987, Journal of immunology.

Accelerated myelopoietic recovery in irradiated mice treated with Photofrin.

E. Waterfield, J. Levy, D. Hunt, 1995, International journal of immunopharmacology.

New Applications in Photodynamic Therapy Introduction

M. Obochi, J. Levy, Modestus Obochi, 1996, Photochemistry and photobiology.

Isolation of a T-cell clone that reacts with both antigen and anti-idiotype: evidence for anti-idiotype as internal image for antigen at the T-cell level.

J. Levy, R. Singhai, 1987, Proceedings of the National Academy of Sciences of the United States of America.

The use of unideterminant fragments of ferredoxin in the genetic mapping of determinant specificity of the immune response.

J. Levy, L. Sikora, M. Weaver, 1982, Molecular immunology.

Genetic control of the immune response to ferredoxin: linkage and mapping of T cell proliferation and antibody production genes to the MHC of mice.

J. Levy, L. Sikora, 1980, Journal of immunology.

Specific helper factors

D. Kilburn, J. Levy, 1980, Cancer Immunology, Immunotherapy.

Monoclonal antibodies to the transforming protein of Fujinami avian sarcoma virus discriminate between different fps-encoded proteins

T. Pawson, J. Levy, E. Hinze, 1984, Journal of virology.

Development of a model to demonstrate photosensitizer‐mediated viral inactivation in blood

J. Levy, F. Tufaro, J G Levy, 1990, Transfusion.

Isolation and partial characterization of immunologically reactive fractions from chitinase digested cell wall of Trichophyton mentagrophytes

J. Levy, B. Kelly, A. Al-Rammahy, 1979, Mycopathologia.

Characterization of immunologically active peptides from the cell wall of T.mentagrophytes

J. Levy, B. Kelly, A. Al-Rammahy, 1979, Mycopathologia.

The effect of haptenic peptides from performic acid oxidized ferredoxin from Clostridium pasteurianum and protein carrier-hapten conjugates on the immune response of macrophages and lymphoid cells from animals immunized against oxidized ferredoxin.

D. Kilburn, J. Levy, R. Teather, 1972, Cellular immunology.

Anti-tumour effects of the sesquiterpene Lactone parthenin.

J. Levy, G. Towers, D. Mew, 1982, Planta medica.

with Photodynamic Therapy Contact Hypersensitivity in Mice Treated IL-10 Contributes to the Inhibition of

J. Levy, D. Hunt, J. Tao, 2013 .

Prolonged skin allograft survival after photodynamic therapy associated with modification of donor skin antigenicity.

M. Obochi, J. Levy, J G Levy, 1997, Transplantation.

The blocking activity of antisera raised to either tumor antigens or alloantigens in cytotoxicity assays using syngeneic or allogeneic killer cells on the P815 murine mastocytoma target.

J. Levy, A. Al-Rammahy, 1980, Cellular Immunology.

Influence of tumor size and surgical resection on cell-mediated immunity in mice.

J. Levy, A. Smith, R. Whitney, 1974, Journal of the National Cancer Institute.

Suppressor cells in the spleens of tumor-bearing mice: enrichment by centrifugation on hypaque-ficoll and characterization of the suppressor population.

D. Kilburn, J. Levy, B. Pope, 1976, Journal of immunology.

Recovery of immune competence after tumour resection in mice: correlation with loss of suppressor elements.

J. Levy, R. Whitney, R. D. Gasocyne, 1978, British Journal of Cancer.

Isolation and partial characterization of a tumor-associated antigen of the P815 mastocytoma of DBA/2 mice.

J. Levy, A. Al-Rammahy, A. Jackson, 1980, Journal of immunology.

Further characterization of thymic suppressor cells and a factor that suppress the generation of cells cytotoxic for a syngeneic tumor in DBA/2 mice.

D. Kilburn, J. Levy, T. Maier, 1979, Journal of immunology.

In vitro induction of cytotoxicity against syngeneic mastocytoma and its suppression by spleen and thymus cells from tumor-bearing mice.

D. Kilburn, F. Takei, J. Levy, 1976, Journal of immunology.

Suppressor deletion therapy. Selective elimination of T suppressor cells using a hematoporphyrin-conjugated monoclonal antibody.

J. Levy, S. Whitney, A. T. Stammers, 1988, Targeted diagnosis and therapy.

Inhibition of murine tumor growth and prostaglandin synthesis by indomethacin

J. Levy, A. Fulton, 1980, International journal of cancer.

Responses of guinea-pig lymphocytes to mitogens, an antigen, and mixed leucocyte culture in media with and without mercaptoethanol and foetal calf serum.

J. Levy, B. Kelly, D. Gregerson, 1975, Immunology.

Suppressor cell-inducing factor: a new lymphokine secreted by a natural suppressor cell line with natural cytotoxic activity. I. Purification to apparent homogeneity and initial characterization of suppressor cell-inducing factor.

W. McMaster, W. Almawi, J. Levy, 1988, Journal of immunology.

Bcl-2 overexpression blocks caspase activation and downstream apoptotic events instigated by photodynamic therapy

B. McManus, J. Levy, D. Granville, 1999, British Journal of Cancer.

Overexpression of Bcl‐XL prevents caspase‐3‐mediated activation of DNA fragmentation factor (DFF) produced by treatment with the photochemotherapeutic agent BPD‐MA

B. McManus, J. Levy, D. Granville, 1998, FEBS letters.

Stimulation of Stress-activated Protein Kinase and p38 HOG1 Kinase in Murine Keratinocytes following Photodynamic Therapy with Benzoporphyrin Derivative*

S. Pelech, J. Sanghera, J. Levy, 1996, The Journal of Biological Chemistry.

Photodynamic inactivation of retrovirus by benzoporphyrin derivative: a feline leukemia virus model

J. Overbaugh, J. Levy, R. Lansman, 1992, Transfusion.

Immune competence and immunosuppressive factors in splenectomized tumor-bearing mice.

J. Levy, B. Pope, R. Whitney, 1977, Cellular immunology.

Photofrin increases murine spleen cell transferrin receptor expression and responsiveness to recombinant myeloid and erythroid growth factors.

J. Levy, D. Hunt, H. Jiang, 1998, Immunopharmacology.

Influence of Photofrin on the hematopoietic accessory function of murine peritoneal cells.

J. Levy, D. Hunt, 1997, Immunopharmacology and immunotoxicology.

Reduced xenograft rejection in rat striatum after pretransplant photodynamic therapy of murine neural xenografts.

C. Honey, M. Obochi, J. Levy, 2000, Journal of neurosurgery.

Properties of syngeneic and allogeneic antisera raised to tumor-specific suppressor factor from DBA/2J mice

D. Kilburn, J. Levy, T. Maier, 1981, Cancer Immunology, Immunotherapy.

Detection of a tumor-associated antigen on the surface of human myelogenous leukemia cells.

R. Shipman, J. Levy, A. Malcolm, 1982, Journal of immunology.

The role of suppressor factors in the regulation of immune responses by ultraviolet radiation-induced suppressor T lymphocytes. III. Isolation of a suppressor factor with the B16G monoclonal antibody.

M. Kripke, S. Ullrich, J. Levy, 1989, Cellular immunology.

Epitope Specificity and Quantification of Antisera

J. Levy, L. Sikora, R. Singhai, 2003 .

Identification of an idiotypic marker of a major regulatory T cell of the immune response in B10.BR mice to ferredoxin. The relationship of idiotypic regulation to conventional hapten-carrier effects

J. Levy, L. Sikora, R. Singhai, 1983, The Journal of experimental medicine.

Preadministration of a T-suppressor factor enhances tumor immunity in DBA/2 mice

J. Levy, A. T. Stammers, J. Steele, 2004, Cancer Immunology, Immunotherapy.

Anti-tumor effects of an antiserum raised in syngeneic mice to a tumor-specific T suppressor factor

J. Levy, T. Maier, 1982, Cancer Immunology, Immunotherapy.

The immune response to ferredoxin: characterization of a major idiotype in serum using monoclonal antibody derived by cell fusion.

J. Levy, L. Sikora, M. Weaver, 1982, Molecular immunology.

Selective elimination of malignant stem cells using photosensitizers followed by light treatment

J. Levy, C. Jamieson, C. Dowding, 1995, Stem cells.

Immunomodulatory aspects of photodynamic therapy.

J. Levy, D. Hunt, 1998, Expert opinion on investigational drugs.

New trends in photobiology

J. North, J. Levy, H. Neyndorff, 1993 .

Photosensitizers as virucidal agents.

J. Levy, J. North, H. Neyndorff, 1993, Journal of photochemistry and photobiology. B, Biology.

Relative sensitivity of leukemic (CML) and normal progenitor cells to treatment with the photosensitizer benzoporphyrin derivative and light.

A. Hornby, A. Richter, J. Levy, 1993, Journal of hematotherapy.

A specific helper factor which enhances the cytotoxic response to a syngeneic tumour

D. Kilburn, J. Levy, H. Teh, 1979, Nature.

Photodynamic Alteration of the Surface Receptor Expression Pattern of Murine Splenic Dendritic Cells

M. Obochi, J. Levy, D. Hunt, 1999, Scandinavian journal of immunology.

Characterization of a soluble factor that specifically suppresses the in vitro generation of cells cytotoxic for syngeneic tumor cells in mice.

D. Kilburn, F. Takei, J. Levy, 1978, Journal of immunology.

Characterization of suppressor cells in mice bearing syngeneic mastocytoma.

D. Kilburn, F. Takei, J. Levy, 1977, Journal of immunology.

Immunosuppression in mice bearing primary tumors.

J. Levy, B. Kelly, R. Whitney, 1978, European journal of cancer.

Selective binding of chemically defined antigenic peptides to mouse lymphocytes

J. Levy, B. Kelly, B. Kaye, 1974, European journal of immunology.

Nuclear factor-κB activation by the photochemotherapeutic agent verteporfin

J. Piette, C. Carthy, J. Levy, 2000 .

Nuclear factor-kappaB activation by the photochemotherapeutic agent verteporfin.

B. McManus, J. Piette, C. Carthy, 2000, Blood.

IL-10 Contributes to the Inhibition of Contact Hypersensitivity in Mice Treated with Photodynamic Therapy

J. Levy, D. Hunt, J. Tao, 2000, The Journal of Immunology.

Interleukin-12 reverses the inhibitory impact of photodynamic therapy (PDT) on the murine contact hypersensitivity response

Julia G. Levy, David W. C. Hunt, Guillermo O. Simkin, 1998, Photonics West - Biomedical Optics.

Effect of photodynamic therapy using benzoporphyrin derivative on the cutaneous immune response

Julia G. Levy, David W. C. Hunt, Guillermo O. Simkin, 1995, Photonics West.

Synergism between immune complexes and serum from tumor-bearing mice in the suppression of mitogen responses.

D. Kilburn, J. Levy, M. Fairhurst, 1976, Journal of immunology.

Mode of action of immunosuppressive substances in sera of tumor-bearing mice.

J. Levy, R. Whitney, 1975, Journal of the National Cancer Institute.

Effects of sera from tumor-bearing mice on mitogen and allogeneic cell stimulation of normal lymphoid cells.

J. Levy, R. Whitney, 1975, Journal of the National Cancer Institute.

Helper cells active in the generation of cytotoxicity to a syngeneic tumor.

D. Kilburn, J. Levy, E. J. Hancock, 1981, Journal of immunology.

Two distinct populations of suppressor cells in the spleens of mice bearing methylcholanthrene-induced tumors.

J. Levy, B. Pope, R. Whitney, 1978, Journal of immunology.

The influence of allogeneic or syngeneic cell surface backgrounds on the antibody response of mice to rabbit Fab' fragments.

J. Levy, R. Acres, Julia G. Levy, 1977, Cellular immunology.

Evidence for a common leukemia-associated antigen in acute myelogenous leukemia

J. Levy, A. Malcolm, S. Shipman, 1980, Cancer Immunology, Immunotherapy.

VIP-innervation of rat intestine: A developmental study with monoclonal antibodies

J. Brown, C. Mcintosh, J. Levy, 1984, Peptides.

Immunization of DBA/2 mice with a T cell hybridoma-derived TsF increases immune resistance to the syngeneic tumors P815 and L1210.

J. Levy, A. T. Stammers, J. Steele, 1986, Journal of Immunology.

Characterization of a monoclonal antibody directed to a T cell suppressor factor.

J. Levy, A. T. Stammers, T. Maier, 1983, Journal of Immunology.

Isolation and characterization of a T-suppressor factor specific for the lupus-associated autoantigen RNP-Sm.

J. Levy, J. Waterfield, J. Steele, 1989, Autoimmunity.

Isolation of functional polyclonal TsF from MRL-lpr spleens using monoclonal antibody absorbance.

J. Levy, J. Waterfield, A. T. Stammers, 1986, Cellular immunology.

Viral inactivation in blood and red cell concentrates with benzoporphyrin derivative.

J. Levy, J. North, D. King, 1992, Blood cells.

Photodynamic Treatment with Benzoporphyrin Derivative Monoacid Ring A Produces Protein Tyrosine Phosphorylation Events and DNA Fragmentation in Murine P815 Cells

J. Levy, D. Granville, D. Hunt, 1998, Photochemistry and photobiology.

Consequences of the photodynamic treatment of resting and activated peripheral T lymphocytes.

J. Levy, D. Granville, D. Hunt, 1999, Immunopharmacology.

Photodynamic therapy; a comparison with other immunomodulatory treatments of adjuvant‐enhanced arthritis in MRL‐lpr mice

J D Waterfield, J. Levy, J G Levy, 1994, Clinical and experimental immunology.

Photodynamic therapy inhibits cell adhesion without altering integrin expression.

J. Levy, J G Levy, P Margaron, 1997, Biochimica et biophysica acta.

Preliminary Studies on aMore Effective Phototoxic Agent ThanHematoporphyrin 1

David, A. Richter, J. Levy, 2022 .

Photoimmunotherapy: treatment of animal tumors with tumor-specific monoclonal antibody-hematoporphyrin conjugates.

J. Levy, G. Towers, J G Levy, 1983, Journal of immunology.

Amelioration of antigen-induced arthritis in rabbits by induction of apoptosis of inflammatory cells with local application of transdermal photodynamic therapy.

E. Keystone, A. Iamaroon, A. Richter, 1998, Arthritis and rheumatism.

SENSITIVITY OF ACTIVATED MURINE PERITONEAL MACROPHAGES TO PHOTODYNAMIC KILLING WITH BENZOPORPHYRIN DERIVATIVE

J. Levy, D. Hunt, A. Chan, 1995, Photochemistry and photobiology.

STRESS PROTEIN EXPRESSION IN MURINE TUMOR CELLS FOLLOWING PHOTODYNAMIC THERAPY WITH BENZOPORPHYRIN DERIVATIVE

J. Levy, J G Levy, P M Curry, 1993, Photochemistry and photobiology.

Anti-tumour effects of the sesquiterpene lactone parthenin.

J. Levy, G. Towers, D. Mew, 1982, Planta medica.

Delivery of Benzoporphyrin Derivative, a Photosensitizer, into Atherosclerotic Plaque of Watanabe Heritable Hyperlipidemic Rabbits and Balloon‐Injured New Zealand Rabbits

Anil K. Jain, A. Richter, B. Allison, 1997, Photochemistry and photobiology.

Photodynamic inactivation of free and cell-associated HIV-1 using the photosensitizer, benzoporphyrin derivative.

J. Levy, R. Coombs, J. North, 1994, Journal of acquired immune deficiency syndromes.

Biodistribution of tritiated benzoporphyrin derivative (3H-BPD-MA), a new potent photosensitizer, in normal and tumor-bearing mice.

D. Dolphin, E. Sternberg, A. Richter, 1990, Journal of photochemistry and photobiology. B, Biology.

Suppression of mitogen responses by serum from tumour-bearing mice.

J. Levy, R. Whitney, 1974, European journal of cancer.

Uptake of Verteporfin® by articular tissues following systemic and intra‐articular administration

A. Richter, J. Levy, J. Waterfield, 1998, Biopharmaceutics & drug disposition.

Photodynamic elimination of clonogenic Ph+ chronic myeloid leukemia cells.

X. H. Wang, A. Hornby, A. Keating, 1993, Leukemia & lymphoma.

Early release of mitochondrial cytochrome c and expression of mitochondrial epitope 7A6 with a porphyrin-derived photosensitizer: Bcl-2 and Bcl-xL overexpression do not prevent early mitochondrial events but still depress caspase activity.

B. McManus, C. Rudin, C. Thompson, 1999, Laboratory investigation; a journal of technical methods and pathology.

Inhibition of contact hypersensitivity with different analogs of benzoporphyrin derivative.

J. Levy, D. Hunt, A H Chan, 1997, Immunopharmacology.

Transcutaneous Photodynamic Therapy Alters the Development of an Adoptively Transferred Form of Murine Experimental Autoimmune Encephalomyelitis

J. Levy, D. Hunt, S Leong, 1996, Photochemistry and photobiology.

The use of transcutaneous photodynamic therapy in the prevention of adjuvant-enhanced arthritis in MRL/lpr mice.

J D Waterfield, M. Obochi, A. Richter, 1994, Clinical immunology and immunopathology.

Ability of specific monoclonal antibodies and conventional antisera conjugated to hematoporphyrin to label and kill selected cell lines subsequent to light activation.

M W Berns, R J Walter, M. Berns, 1985, Cancer research.

Photodynamic therapy of malignancies with benzoporphyrin derivative monoacid ring A

R. Rox Anderson, Julia G. Levy, Claire Smits, 1994, Other Conferences.

Preliminary studies on a more effective phototoxic agent than hematoporphyrin.

D. Dolphin, A. Richter, J. Levy, 1987, Journal of the National Cancer Institute.

The detection by immunodiffusion of tumour associated antigenic components in extracts of human bronchongenic carcinoma.

R. Watson, J. Levy, A. Smith, 1975, British Journal of Cancer.

Tumour-associated antigens in lung cancer: the possibility for a serologic assay.

J. Levy, B. Kelly, 1980, Canadian Medical Association journal.

Detection of tumour-associated antigens in human bronchogenic carcinoma by the enzyme-linked immunosorbent assay (ELISA).

J. Levy, B. Kelly, 1980, British Journal of Cancer.

Purification of a protein associated with human bronchogenic squamous-cell carcinoma.

J. Levy, B. Kelly, 1979, British Journal of Cancer.

Evidence for a common tumour-associated antigen in extracts of human bronchogenic carcinoma.

J. Levy, B. Kelly, 1977, British Journal of Cancer.

The Use of Immunoadsorbent Columns for the Isolation of Antibodies Specific for Antigens Associated with Human Bronchogenic Carcinoma

R. Watson, J. Levy, A. Smith, 1974, British Journal of Cancer.

THE EFFECTS OF PLASMA LIPOPROTEINS ON in vitro TUMOR CELL KILLING and in vivo TUMOR PHOTOSENSITIZATION WITH BENZOPORPHYRIN DERIVATIVE

A. Richter, E. Waterfield, B. Allison, 1991, Photochemistry and photobiology.

Photofrin, but not benzoporphyrin derivative, stimulates hematopoiesis in the mouse.

J. Levy, D. Hunt, C. Smits, 1993, Immunopharmacology.

Cellular and humoral immune responses in guinea pigs and rabbits to chemically defined synthetic peptides

J. Levy, B. Kelly, D. Hull, 1973, European journal of immunology.

Analysis of human myelogenous leukemia cells in the fluorescence- activated cell sorter using a tumor-specific antiserum

R. Shipman, J. Levy, A. Malcolm, 1983 .

Analysis of human myelogenous leukemia cells in the fluorescence-activated cell sorter using a tumor-specific antiserum.

R. Shipman, J. Levy, A. Malcolm, 1983, Blood.

Characterization Of Benzoporphyrin Derivative, A New Photosensitizer

Julia G. Levy, Anna M. Richter, Ethan Sternberg, 1989, Other Conferences.

In vitro AND in vivo UPTAKE OF BENZOPORPHYRIN DERIVATIVE INTO HUMAN AND MINISWINE ATHEROSCLEROTIC PLAQUE

A. Richter, J. Levy, A K Jain, 1993, Photochemistry and photobiology.

Photosensitising potency of structural analogues of benzoporphyrin derivative (BPD) in a mouse tumour model.

A. Jain, D. Dolphin, E. Sternberg, 1991, British Journal of Cancer.

The induction of nonspecific T suppressor lymphocytes by prostaglandin E1.

J. Levy, A. Fulton, 1981, Cellular immunology.

THE PLASMA DISTRIBUTION OF BENZOPORPHYRIN DERIVATIVE and THE EFFECTS OF PLASMA LIPOPROTEINS ON ITS BIODISTRIBUTION

A. Richter, B. Allison, J. Levy, 1990, Photochemistry and photobiology.

In vitro EVALUATION OF PHOTOTOXIC PROPERTIES OF FOUR STRUCTURALLY RELATED BENZOPORPHYRIN DERIVATIVES

D. Dolphin, E. Sternberg, A. Richter, 1990, Photochemistry and photobiology.

MODIFIED POLYVINYL ALCOHOL‐BENZOPORPHYRIN DERIVATIVE CONJUGATES AS PHOTOTOXIC AGENTS

A. Richter, J. Levy, Dan Liu, 1993, Photochemistry and photobiology.

Immunological effects of photodynamic therapy

Stephen Yip, Julia G. Levy, Anna M. Richter, 1990, Photonics West - Lasers and Applications in Science and Engineering.

Characteristics of an antigen-specific helper factor that enhances the in vitro generation of cytotoxic cells directed against a syngeneic tumor.

D. Kilburn, J. Levy, F. Talbot, 1981, Journal of immunology.

The porphyrin photosensitizer Photofrin elevates murine splenic erythropoiesis.

J. Levy, D. Hunt, H. Jiang, 1998, Immunopharmacology and immunotoxicology.

Evidence for low-density lipoprotein receptor-mediated uptake of benzoporphyrin derivative.

B. Allison, J. Levy, P. Pritchard, 1994, British Journal of Cancer.

Biodistribution of a benzoporphyrin derivative-monoclonal antibody conjugate in A549-tumor-bearing nude mice.

A. Jain, A. Richter, J. Levy, 1993, Biotechnology therapeutics.

Characterization of a T-lymphocyte inhibitor in the serum of tumour-bearing mice.

D. Kilburn, J. Levy, A. Smith, 1976, Immunology.

Nononcologic potentials for photodynamic therapy

Julia G. Levy, Anna M. Richter, Ashok K. Jain, 1994, Other Conferences.

Purification of an in vitro inhibitor of normal myelopoiesis using a monoclonal antibody directed to a common antigen of myelogenous leukemia (CAMAL).

W. McMaster, J. Shellard, J. Levy, 1991, Experimental hematology.

Clinical Applications of Photodynamic Therapy

T. Dougherty, J. Levy, 2003 .

Clinical status of benzoporphyrin derivative

Julia G. Levy, Agnes H. Chan, H. Andrew Strong, 1996, European Conference on Biomedical Optics.

Immunological studies on the major haptenic peptides from performic acid oxidized ferredoxin from Clostridium pasteurianum.

J. Levy, J G Levy, B. Kelly, 1971, Biochemistry.

Photodynamic immune modulation (PIM)

Julia G. Levy, Harvey Lui, John Robert North, 1999, Other Conferences.

ACTIVATION OF BENZOPORPHYRIN DERIVATIVE IN THE CIRCULATION OF MICE WITHOUT SKIN PHOTOSENSITIVITY

M. Obochi, A. Richter, A. J. Canaan, 1994, Photochemistry and photobiology.

Effect of Porphyrins on the Hematopoietic Recovery of Mice Treated with γ-Radiation

E. Waterfield, J. Levy, D. Hunt, 1994 .

The cellular immune response to synthetic peptides containing sequences known to be heptenic in performic acid-oxidized ferredoxin from Clostridium pasteurianum.

D. Kilburn, J. Levy, B. Kelly, 1972, Cellular immunology.

The preparation of xenoantiserum specific for a murine mastocytoma cell line

J. Levy, A. Al-Rammahy, 1979, Cancer Immunology, Immunotherapy.

T–T interaction in the generation of helper cells in vitro

M. Feldmann, D. Kilburn, J. Levy, 1975, Nature.

Identity of a T-lymphocyte inhibitor with mouse immunoglobulin in the serum of tumour-bearing mice.

D. Kilburn, J. Levy, B. Kelly, 1977, Immunology.

The Relationship of Immune Status to the Efficacy of Immunotherapy in Preventing Tumour Recurrence in Mice

J. Levy, A. Smith, L. Panno, 1974, British Journal of Cancer.